Bidirectional Association between Atrial Fibrillation and Ovarian Cancer: Evidence from the UK Biobank and Mendelian Randomization
Women with AF may represent a high-risk group for ovarian cancer, highlighting the need for cardio-oncology surveillance and biomarker-guided screening strategies.
Authors
- Ling Ding (ORCID: https://orcid.org/0000-0002-3590-7548)
- Z. Zhang (ORCID: https://orcid.org/0009-0008-7117-2121)
- Zhengyu Tao (ORCID: https://orcid.org/0000-0001-7040-042X)
- Wutao Chen (ORCID: https://orcid.org/0000-0002-1141-1433)
- Xinning Guo (ORCID: https://orcid.org/0009-0009-6402-6422)
- Na Zhang (ORCID: https://orcid.org/0000-0003-3719-4008)
- Qiming Liu (ORCID: https://orcid.org/0000-0002-7928-4557)
- Jun Pu (ORCID: https://orcid.org/0000-0003-2240-5108)
- Meng Jiang (ORCID: https://orcid.org/0000-0003-3180-8419)
- Yu Zhong (ORCID: https://orcid.org/0009-0002-0759-1221)
- Chen Wu (ORCID: https://orcid.org/0000-0002-2315-3945)
Institutions
- Shanghai Jiao Tong University (CN)
- Beijing Chao-Yang Hospital, Capital Medical University (CN)
- Renji Hospital (CN)
- Sinovac Biotech (CN)
- Shanghai Cancer Institute (CN)
- State Key Laboratory of Oncogene and Related Genes (CN)
- Viva Biotech (China) (CN)
- Beijing Chaoyang Emergency Medical Center (CN)
Publication Details
- Journal
- Cancer Epidemiology Biomarkers & Prevention
- Published
- 2025-11-07
- DOI
- https://doi.org/10.1158/1055-9965.epi-25-0949
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shanghai Municipal Health Commission
- National Natural Science Foundation of China